Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.56 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | BID | P55957 | 3/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.44 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.44 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.44 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.44 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31005145 | 1.00 | LIPG (0.56) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL3188722 | 1.00 | LIPG (0.56) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL7528453 | 0.92 | LIPG (0.46) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL247026 | 0.89 | LIPG (0.50) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL31005121 | 0.89 | LIPG (0.50) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL3214972 | 0.89 | LIPG (0.50) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL15809821 | 0.83 | LIPG (0.69) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL10980560 | 0.83 | LIPG (0.69) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL18496530 | 0.83 | LIPG (0.69) | LIPGNR1H2NR1H3BIDMCL1 | |
| SCHEMBL10755599 | 0.83 | LIPG (0.69) | LIPGNR1H2NR1H3BIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399592-B2 | Polyhedral polysiloxane modified product and composition using the modified product | KANEKA CORPORATION (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20100099790-A1 | POLYHEDRAL POLYSILOXANE MODIFIED PRODUCT AND COMPOSITION USING THE MODIFIED PRODUCT | KANEKA CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2151443-A1 | POLYHEDRAL POLYSILOXANE MODIFIED PRODUCT AND COMPOSITION USING THE MODIFIED PRODUCT | Kaneka Corporation (JP) | 2010-02-10 | — | — | EP | disclosed |
| EP-0966503-B2 | CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY | MINNESOTA MINING & MFG (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-0966503-B1 | CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY | MINNESOTA MINING & MFG (US) | 2003-05-28 | — | — | EP | disclosed |
| US-6204350-B1 | POLYMER HAVING REACTIVE END GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-03-20 | — | — | US | disclosed |
| EP-0966503-A1 | CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998040439-A1 | CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099790-A1 | POLYHEDRAL POLYSILOXANE MODIFIED PRODUCT AND COMPOSITION USING THE MODIFIED PRODUCT | SMCHD1, CNOT9, SMC4 | LIPG 4250/4885NR1H2 4320/4885NR1H3 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.